Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Phusis Therapeutics (United States) | Researchclopedia

Back to institutions

Phusis Therapeutics (United States)

San Diego, Californiacompany

39

Works

1,959

Citations

28

h-index

Top Research Topics

Radiopharmaceutical Chemistry and Applications PI3K/AKT/mTOR signaling in cancer Glioma Diagnosis and Treatment

Top Researchers

Roy S. Herbst Yale New Haven Hospital

1,328 works92,846 citationsh-index: 134

Recent Research

26-A-10902-ACC A PHASE 1 DOSE-ESCALATION AND -EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SUBCUTANEOUSLY ADMINISTERED SRSD216 IN PATIENTS WITH ELEVATED LIPOPROTEIN(A)

Patrick Yue,Lingling Gu,et al.

20260 citations

Brain Metastases and Treatment

Advanced Breast Cancer Therapies

Protein Kinase Regulation and GTPase Signaling

Computational Drug Discovery Methods

Prostate Cancer Treatment and Research

Cancer-related Molecular Pathways

Microtubule and mitosis dynamics

Immunotherapy and Immune Responses

Monoclonal and Polyclonal Antibodies Research

Garth Powis The University of Texas MD Anderson Cancer Center

621 works27,256 citationsh-index: 86

Marc H. Hedrick Phusis Therapeutics (United States)

126 works25,046 citationsh-index: 45

Michael Newman Royal Devon & Exeter NHS Foundation Trust

243 works8,845 citationsh-index: 45

Mike Scott West Texas A&M University

79 works8,451 citationsh-index: 30

Catherine C. Turkel Phusis Therapeutics (United States)

65 works6,965 citationsh-index: 31

Enhanced sampling and ligandability assessment to expand the repertoire of potentially druggable cryptic pockets

Neha Vithani,She Zhang,et al.

20260 citations

Barriers to clinical trial access among Black lupus patients

Shae Chambers,A. Ross Hill,et al.

20250 citations

CTNI-67. PHASE 1 MULTICENTER STUDY OF MULTIPLE DOSES OF RHENIUM (186RE) OBISBEMEDA (REYOBIQ) FOR LEPTOMENINGEAL METASTASES: RATIONALE, DESIGN, AND PRELIMINARY COHORT 1 DATA

Andrew Brenner,Priya Kumthekar,et al.

20250 citations

IMG-94. Assessment of rhenium-186 obisbemeda (186RNL) therapy for recurrent glioblastoma (rGBM) using MRI and SPECT imaging biomarkers

Shi‐Liang Huang,Michael Youssef,et al.

20250 citations

CTNI-43. PHASE 1/2 RESPECT-GBM TRIAL OF RHENIUM (186RE) OBISBEMEDA IN RECURRENT GLIOBLASTOMA: SAFETY AND EFFICACY FROM THE PHASE 1 AND UPDATE ON PHASE 2

Andrew Brenner,M. S. K. YOUSSEF,et al.

20250 citations